Screener
Syndax Pharmaceuticals SNDX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's invested capital?
- Syndax Pharmaceuticals (SNDX) reported invested capital of $261.22M in Q1 2026.
- How has Syndax Pharmaceuticals's invested capital changed year-over-year?
- Syndax Pharmaceuticals's invested capital decreased by 34.3% year-over-year, from $397.3M to $261.22M.
- What is the long-term trend for Syndax Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's invested capital has grown at a 15.4% compound annual growth rate (CAGR), from $137.36M to $281.22M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Syndax Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude